Q&A: Tom Sellig on Why Complex Formulations Are Driving CDMO GrowthByTom Sellig,Zachary ZubulakeJune 12th 2026
Overcoming Fill-Finish Capacity Bottlenecks in Automated Pen Injector Assembly LinesByJordan XuJune 11th 2026
USP Reports Drug Discontinuations on the RiseBySusan HaigneyPublished: June 9th 2026 | Updated: June 10th 2026
CPHI Americas: The Business Case for Product Carbon Footprints in PharmaByDavid Vázquez,Zachary ZubulakeJune 8th 2026